DS InPharmatics' Senior Drug Substance Consultant, James Mencel, joins the show to share his background with CMC management. In this episode, Ed, Meranda and James discuss the impact that expedited drug development programs have had on the pharma industry. They break down regulations, breakthrough designations and best practices when it comes to these programs.
Leadership – https://dsinpharmatics.com/leadership/#leadership
Project Management – https://dsinpharmatics.com/leadership#projectmanagement
Analytical – https://dsinpharmatics.com/leadership#analytical
Drug Substance – https://dsinpharmatics.com/leadership#drugsubstance
Drug Product – https://dsinpharmatics.com/leadership#drugproduct
Regulatory – https://dsinpharmatics.com/leadership#regulatory
Quality Assurance – https://dsinpharmatics.com/leadership#qualityassurance
Biologics & Microbiology – https://dsinpharmatics.com/leadership#biologics
Formulation & Clinical Ops – https://dsinpharmatics.com/leadership#formulation
Design Space InPharmatics – LinkedIn